The University of the Witwatersrand, Johannesburg, is a multi-campus South African public research university situated in the northern areas of central Johannesburg. It is more commonly known as Wits University or Wits.

During the past decade, University of the Witwatersrand conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of the Witwatersrand" #1 sponsor was "AIDS Clinical Trials Group" with 8 trials, followed by "AIDS Malignancy Consortium" with 2 trials sponsored, "Advanced Imaging Projects, LLC" with 1 trials sponsored, "Enanta Pharmaceuticals, Inc" with 1 trials sponsored and "Foundation for Innovative New Diagnostics, Switzerland" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of the Witwatersrand" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 8 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "The Emmes Company, LLC" with 2 trials as a collaborator, "University of Arkansas" with 2 trials as a collaborator and "University of Cape Town" with 2 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "University of the Witwatersrand" are "HIV Infections" (4 trials), "HIV-1 Infection" (4 trials), "HIV Infection" (3 trials), "Tuberculosis" (3 trials) and "AIDS-Related Human Papillomavirus Infection" (1 trials). Many other conditions were trialed in "University of the Witwatersrand" in a lesser frequency.

Most popular intervention types in "University of the Witwatersrand" are "Drug" (7 trials), "Behavioral" (3 trials), "Biological" (2 trials), "Diagnostic Test" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lamivudine" (2 trials), "Lopinavir/Ritonavir" (2 trials), "Abacavir" (1 trials), "Abacavir/lamivudine" (1 trials) and "Abacavir/lamivudine/zidovudine" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of the Witwatersrand" are 9 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "University of the Witwatersrand". 1 are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in University of the Witwatersrand, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of the Witwatersrand, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".

University of the Witwatersrand has several departments that took part in Clinical trials: "Charlotte Maxeke Johannesburg Academic Hospital" - 32 trials, "Wits Reproductive Health and HIV Institute Clinical Research Site" - 2 trials, "Carbohydrate and Lipid Metabolism Research Unit" - 3 trials, "University Witwatersrand Oncology" - 2 trials, "University of Witwatersrand/Helen Joseph Hospital" - 2 trials, "Clinical HIV Research Unit (CHRU), Wits Health Consotium (Pty) Ltd" - 2 trials